Betta Pharmaceuticals Co., Ltd.
Status: Publicly traded
Direct answer
Betta Pharmaceuticals Co., Ltd. is publicly traded on SHZ under the ticker 300558.SZ.
Betta Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of oncology treatments. Among its key offerings are Icotinib hydrochloride, an orally taken epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and Ensartinib hydrochloride, an anaplastic lymphoma kinase (ALK) inhibitor, both utilized in the management of...
Can you invest in Betta Pharmaceuticals Co., Ltd.?
Yes. Betta Pharmaceuticals Co., Ltd. is publicly traded on SHZ under the ticker 300558.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Betta Pharmaceuticals Co., Ltd.
Detailed equity research is provided by MarketSnap.